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Chagas disease, characterized by chronic cardiomyopathy, is 
caused by infection with the intracellular protozoan parasite 
Trypanosoma cruzi (Bonney et al., 2015). The TLR-MyD88/
TRIF adaptor molecule pathways initiate both innate and 
adaptive immune responses, and thus contribute to the resis-
tance of the host to intracellular protozoan parasites such as 
T. cruzi (Gazzinelli and Denkers, 2006; Kayama and Takeda, 
2010; Kawai and Akira, 2011; Rodrigues et al., 2012). Re-
cently, several studies have demonstrated the mechanisms un-
derlying the TLR-independent host defense against T. cruzi 
infection, such as TLR-independent T-helper 1 (Th1) re-
sponses (Kayama et al., 2009).
Th17 cells, which produce IL-17A, IL-17F, IL-22, and 
GM-CSF, play essential roles in the immune response to in-
fection (Miyazaki et al., 2010; McGeachy and McSorley, 2012; 
Bermejo et al., 2013). Th17 cell differentiation is induced by 
IL-6 and TGF-β, and IL-23 mediates the enhanced produc-
tion of Th17 cell–related cytokines (Gaffen et al., 2014). IL-
17A–producing CD4+ T cells are greatly increased in mice 
infected with T. cruzi (da Matta Guedes et al., 2010), and a 
lack of IL-17A is linked to the aggravation of the parasite bur-
den and the failure of various organs after T. cruzi infection 
(da Matta Guedes et al., 2010; Miyazaki et al., 2010). These 
findings indicate that adequate IL-17 responses are required 
for host protection, but that enhanced IL-17 production can 
cause tissue immunopathology during infection with intra-
cellular protozoan parasites. Several studies have demonstrated 
that the Th17 response, particularly induction of Th17 cell de-
velopment, is tightly regulated by several mechanisms during 
the course of parasite infection. For example, the IL-27/
WSX-1 signaling pathway plays an important role in the neg-
ative regulation of IL-17 production by CD4+ T cells during 
T. cruzi and Toxoplasma gondii infection (Stumhofer et al., 
2006; Yoshimura et al., 2006), and the T cell-intrinsic tran-
scription factor T-bet, encoded by Tbx21, contributes to the 
inhibition of T. cruzi–specific Th17 cell differentiation (Guo 
et al., 2009). IL-12p35 also down-regulates Th17 responses to 
T. cruzi (Cobb and Smeltz, 2012). However, it remains un-
clear how Th17 cell responses are controlled after induction.
IL-23, a heterodimer of the IL-23p19 and IL-12p40 
subunits, is essential for the generation of pathogenic Th17 
cells (McGeachy et al., 2009; Gaffen et al., 2014). In exper-
imental autoimmune myocarditis (EAM), IL-23 functions 
as a key effector molecule by promoting the production of 
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IL-17 by lymphocytes (Rangachari et al., 2006). IL-23 is also 
implicated in the development of colitis by stimulating the 
accumulation of Th17 cells (Ahern et al., 2010). In contrast, 
another study has shown that induction of histone modifica-
tion by IFN-γ was linked to the suppression of Il23a expres-
sion, which encodes IL-23p19, in intestinal CD11b+ Mφs, 
thus preventing colitis (Sheikh et al., 2010). The IFN-γ re-
leased by CD8+ T cells also suppresses the development of 
EAM through inhibition of IL-17 production (Rangachari et 
al., 2006). These findings indicate that the IL-23–Th17 axis 
is tightly regulated by IFN-γ in a variety of contexts. T. cruzi 
infection induces IL-23 production by host immune cells, and 
antigen-specific Th17 responses are then promoted (Cobb 
et al., 2010; Erdmann et al., 2013). However, whether the 
IL-23–Th17 axis is controlled by IFN-γ–dependent mecha-
nisms during T. cruzi infection remains unclear.
Transcription factor BATF2 was initially identified as an 
AP-1 inhibitor (Su et al., 2008). In cancer cells, BATF2 sup-
presses the expression of AP-1–dependent genes through its 
interaction with c-JUN (Su et al., 2008). In contrast, BATF2 
functions as a transcriptional activator in BM-derived macro-
phages (Mφs [BMMφs]) by interacting with IRF1 in response 
to IFN-γ and the TLR4 ligand LPS (Roy et al., 2015). BATF2 
also compensates CD103+ DC development in Batf3−/− mice 
(Tussiwand et al., 2012). We previously demonstrated that 
BATF2 is normally induced in Myd88−/−Trif −/− BM-de-
rived DCs (BMDCs) during T. cruzi infection (Kayama et 
al., 2009). However, the roles of IFN-γ–inducible BATF2 in 
T. cruzi–infected innate immune cells are poorly understood.
In this study, we demonstrate the mechanism by which 
BATF2 regulates T. cruzi–specific IL-17 production by CD4+ 
T cells. IFN-γ–inducible BATF2 inhibits Il23a expression in 
DCs and Mφs during T. cruzi infection by disrupting the 
formation of the c-JUN–ATF-2 complex by directly bind-
ing to c-JUN, thus preventing Th17-mediated tissue dam-
age during T. cruzi infection. Therefore, BATF2-mediated 
modulation of the IL-23–Th17 axis is involved in host resis-
tance to T. cruzi infection.
resuLts
IFn-γ–induced expression of BAtF2
We previously demonstrated the TLR-independent expres-
sion of 4933430F08Rik, encoding BATF2, in T. cruzi–infected 
BMDCs (Kayama et al., 2009). To assess the physiological role 
of BATF2 during T. cruzi infection, we generated Batf 2−/− 
mice with gene targeting (Fig. S1, A and B). Stimulation with 
LPS plus IFN-γ robustly induced BATF2 mRNA in wild-
type BMMφs, but not Batf2−/− BMMφs (Fig. S1 C). In wild-
type BMMφs, IFN-γ, but not LPS, induced high levels of 
Batf 2 expression (Fig. S1 D). The expression of the mRNAs 
of other BATF family members, such as BATF and BATF3, 
was not induced by IFN-γ in BMMφs (Fig. S1 E). Moreover, 
BATF2 deficiency did not lead to the compensatory up-reg-
ulation of Batf and Batf3 expression, as previously described 
(Roy et al., 2015; Fig. S1 E). A subset of TLR-independent 
genes shown to be expressed in Myd88−/−Trif −/− BMDCs 
during T. cruzi infection (Kayama et al., 2009) was normally 
induced in Batf 2−/− BMMφs stimulated with IFN-γ (Fig. S1 
F). These results indicate that BATF2 is not involved in the 
expression of a subset of IFN-γ–inducible genes.
To determine whether BATF2 is responsible for im-
mune cell development, we analyzed the composition of 
both lymphocytes and innate myeloid cells in the spleens of 
wild-type and Batf2−/− mice (Fig. S1 G). The frequencies and 
total cell numbers of the CD11c+ CD103+, CD11b+ Ly-6C+, 
CD11b+ Ly-6G+, CD3+ CD4+, CD3+ CD8+, and B220+ 
CD19+ cell populations were not altered in the Batf2−/− 
mice, demonstrating that the development of neither innate 
nor adaptive immune cells was affected in Batf2−/− mice.
Increased production of IL-17, but not IFn-γ, by cd4+ t cells 
in t. cruzi–infected Batf2−/− mice
The TLR-independent production of IFN-γ by innate im-
mune cells is implicated in driving Th1 responses during T. 
cruzi infection (Kayama et al., 2009). Because BATF2 was 
shown to be induced by a TLR-independent IFN-γ–depen-
dent mechanism, we analyzed whether BATF2 is responsible 
for the induction of Th1 responses during T. cruzi infection. 
Wild-type and Batf2−/− mice were intraperitoneally infected 
with T. cruzi trypomastigotes. CD4+ T cells were isolated 
from their spleens 0, 15, 20, and 30 d after infection, whereas 
liver CD4+ T cells were isolated 15, 20, and 30 d after in-
fection because there were fewer of these cells in the unin-
fected mice. The isolated CD4+ T cells were stimulated with 
anti-CD3 antibody (Fig. 1 A). The spleen CD4+ T cells of 
T. cruzi–infected wild-type mice showed considerably higher 
production of IFN-γ at 15, 20, and 30 d of infection than 
the uninfected mice, indicating induction of an intensive Th1 
response. IFN-γ production by the spleen CD4+ T cells of T. 
cruzi–infected Batf 2−/− mice was similar to that of wild-type 
mice. Furthermore, no difference in IFN-γ production was 
observed in liver CD4+ T cells of the wild-type and Batf2−/− 
mice after T. cruzi infection (Fig.  1  B). We next analyzed 
antigen-specific Th1 responses after infection by stimulating 
CD4+ T cells with freeze-thawed T. cruzi in the presence of 
antigen-presenting cells (Fig. 1, C and D). IFN-γ production 
by the Batf 2−/− CD4+ T cells from the spleen and liver at any 
time point of infection was similar to that by wild-type CD4+ 
T cells, indicating that the Th1 responses during T. cruzi in-
fection were not impaired in Batf 2−/− mice.
Recent studies have shown that IL-17 is responsible for 
host resistance to T. cruzi infection (da Matta Guedes et al., 
2010; Miyazaki et al., 2010; Bermejo et al., 2013). Therefore, 
we examined IL-17 production by CD4+ T cells in the spleens 
and livers of T. cruzi–infected mice. More IL-17 was produced 
by CD4+ T cells from the spleens of T. cruzi–infected wild-
type mice stimulated with anti-CD3 antibody than from un-
infected mice (Fig. 1 E). These findings indicate that T. cruzi 
infection causes the induction of Th17 immune responses. At 
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CD4+ T cells stimulated with anti-CD3 antibody was con-
siderably higher in the spleens of T. cruzi–infected Batf2−/− 
mice than in those of wild-type mice (Fig. 1 E). In the liver, 
IL-17 production by anti-CD3 antibody–stimulated Batf 2−/− 
CD4+ T cells was greatly increased at 15, 20, and 30 d of 
infection compared with wild-type cells (Fig. 1 F). Further-
more, antigen-specific IL-17 production was markedly higher 
after T. cruzi infection in Batf 2−/− spleen and liver CD4+ T 
cells than in the corresponding wild-type cells (Fig. 1, G and 
H). Intracellular staining analysis also showed that production 
Figure 1. Increased production of IL-17 in cd4+ 
t cells in t. cruzi–infected Batf2−/− mice. (A–H) 
CD4+ T cells were isolated from the spleens (left) and 
livers (right) of wild-type (WT) and Batf2−/− mice at 
0 d (n = 5 per group), 15 d (n = 6 per group), 20 d 
(n = 8 per group), and 30 d (n = 5 per group) of T. 
cruzi infection. Isolated CD4+ T cells were stimulated 
with anti-CD3 antibody (A, B, E, and F) or heat-killed 
T. cruzi (C, D, G, and H) and analyzed for IFN-γ and 
IL-17 with ELI SA. Graphs show mean values ± SEM. *, 
not detected; #, P < 0.05; n.s., not significant. (I and J) 
Expression of Il17a, Il22, Il10, and Ifng in CD4+ T cells 
was isolated from spleens (I) and livers (J) of wild-type 
(n = 5) and Batf2−/− (n = 4) mice after T. cruzi infec-
tion for 20 d (mean values ± SEM). *, P < 0.05; **, P < 
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of IL-17, but not IFN-γ and IL-10, was increased in CD4+ T 
cells from the spleens and livers of T. cruzi–infected Batf2−/− 
mice compared with those from wild-type mice, as indicated 
by increased mean fluorescence intensity of IL-17 (Fig. S2, A, 
B, D, and E). In addition, a higher frequency of IFN-γ+ IL-
17+ CD4+ T cells was observed in the spleens, but not livers, 
of Batf2−/− mice (Fig. S2, C and F). Expression of Th17-re-
lated genes, such as Il17 and Il22, was markedly higher in 
CD4+ T cells from the spleens and livers of T. cruzi–infected 
Batf2−/− mice than in the corresponding cells from wild-
type mice (Fig. 1, I and J), whereas expression of Ifng and 
Il10 in Batf2−/− CD4+ T cells was similar to that in wild-type 
cells. These findings indicate that BATF2 modulates Th17 re-
sponses during T. cruzi infection.
Increased multiorgan pathology in  
t. cruzi–infected Batf2−/− mice
We next assessed parasitemia levels in the blood, livers, and 
hearts of wild-type and Batf2−/− mice after infection, using 
quantitative PCR (qPCR) assay to measure the amounts of T. 
cruzi DNA (Fig. 2 A). In the blood and livers of T. cruzi–in-
fected wild-type mice, the parasite number increased as early 
as 15 d and then gradually decreased. In T. cruzi–infected 
Batf 2−/− mice, the parasite number was reduced, particu-
larly at 20 d of infection, compared with wild-type mice. In 
the hearts of T. cruzi–infected wild-type mice, the parasite 
number increased slowly and reached peak levels at 20 d. 
The parasite number in the hearts was dramatically reduced 
in Batf2−/− mice. In accordance with the reduced parasite 
burden, Batf 2−/− mice showed higher survival rates compared 
with wild-type mice after T. cruzi infection (Fig. 2 B). We 
also analyzed pathological changes (Fig. 3, A and B) in the 
livers and hearts of T. cruzi–infected wild-type and Batf2−/− 
mice. There was greater hepatic inflammation and myocardi-
tis in Batf2−/− mice after T. cruzi infection than in wild-type 
mice. We then measured the concentrations of markers for 
tissue damage: aspartate aminotransferase (AST) in the plasma, 
which is indicative of liver damage; creatinine kinase (CK) in 
the plasma, indicative of heart failure; and creatinine (CRE) 
in the serum, indicative of renal failure (Miyazaki et al., 2010; 
Fig. 3 C). AST, CK, and CRE were markedly higher in T. 
cruzi–infected Batf2−/− mice than in wild-type mice. The 
expression of Mpo, which encodes myeloperoxidase, a tis-
sue-damaging factor produced by neutrophils, was elevated 
in the spleens, livers, and mesenteric LNs (MLNs) of T. cruzi–
infected Batf2−/− mice (Fig. 3 D). We also analyzed the ex-
pression of Th17-related genes, such as Il17a, Il22, and Csf2, 
in the spleens, livers, and MLNs of wild-type and Batf 2−/− 
mice after T. cruzi infection (Fig. 3 E). Expression of these 
Th17-related genes was extremely enhanced in all tissues of 
Batf 2−/− mice compared with those of wild-type mice. Thus, 
enhanced Th17 responses correlated with heightened im-
mune activation and tissue damage, despite reduced parasite 
numbers and mortality, in T. cruzi–infected Batf2−/− mice.
Increased LPs-induced IL-23 production by 
Batf2−/− innate immune cells
To determine the mechanisms by which BATF2 modulates 
Th17 responses during T. cruzi infection, we first examined 
whether T cell-intrinsic BATF2 is involved in either the gen-
eration of Th17 cells or the production of IL-17 by CD4+ T 
cells. Naive CD4+ T cells isolated from the spleens of wild-
Figure 2. Lower levels of parasitemia in 
t. cruzi–infected Batf2−/− mice. (A) Parasite 
equivalents in the livers, hearts, and blood of 
wild-type and Batf2−/− mice 15, 20, and 30 
d after infection (n ≥ 5). #, P < 0.05; ##, P < 
0.009. Data are mean values ± SEM. (B) Mor-
tality of wild-type and Batf2−/− mice after T. 
cruzi infection. Line graphs represent data 
pooled from three independent experiments 
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Figure 3. severe multiorgan pathology in t. cruzi–infected Batf2−/− mice. (A and B) Representative histopathology (A) and histopathological score 
(B) of wild-type (n = 8) and Batf2−/− (n = 9) mice 49 d after infection. Bars, 100 µm. Graphs show mean values ± SD. *, P < 0.01. (C) Concentrations of 
AST and CK in the plasma and CRE in tge sera of T. cruzi–infected wild-type (n ≥ 14) and Batf2−/− (n ≥ 19) mice. *, P < 0.05; **, P < 0.01. Graphs are mean 
values ± SEM. (D) Mpo expression in tissues of wild-type and Batf2−/− mice after T. cruzi infection (n = 3 per group). *, P < 0.05; **, P < 0.02. Data are mean 
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type and Batf2−/− mice were cultured under Th0, Th1, or 
Th17 conditions for 4 d and then analyzed for IFN-γ and 
IL-17 production with intracellular staining and ELI SA. The 
frequency of IL-17–producing cells among Batf2−/− CD4+ 
T cells cultured under Th17 conditions was similar to that 
in wild-type cells (Fig. S3 A). Moreover, IFN-γ–producing 
Batf 2−/− CD4+ T cells maintained under Th1 conditions were 
induced to levels similar to those in wild-type cells. There was 
no significant difference in the secretion of IL-17 or IFN-γ 
by wild-type and Batf2−/− CD4+ T cells stimulated with an-
ti-CD3 antibody (Fig. S3 B), indicating that T cell–intrinsic 
BATF2 does not affect the differentiation of Th1 and Th17 
cells or their cytokine production.
Accumulating evidence has shown that the Th17 re-
sponses are tightly controlled by the innate immune cells 
(Gaffen et al., 2014). Therefore, to determine the functions 
of BATF2 in innate immune responses, we comprehensively 
analyzed the overall gene expression patterns in wild-type 
and Batf 2−/− BMMφs. RNA-seq analysis showed that 98 
genes are up-regulated in Batf2−/− BMMφs stimulated with 
LPS and IFN-γ relative to their expression in wild-type cells 
(Table S1). Among these genes, we focused on Il23a, which 
encodes IL-23p19, because IL-23 promotes the expression of 
Il17a in Th17 cells (Gaffen et al., 2014). To confirm the results 
of the RNA-seq analysis, we examined LPS-induced expres-
sion of Il23a, Il6, Tnf, and Il12b in IFN-γ–pretreated innate 
immune cells prepared from wild-type and Batf2−/− mice, 
using real-time RT-PCR. The expression of Il23a, but not Il6, 
Tnf, or Il12b, was dramatically higher in Batf2−/− Mφs, such 
as peritoneal Mφs (PECs) and BMMφs, than in wild-type 
cells (Fig. 4, A and B). Batf 2−/− BMDCs also showed higher 
expression of Il23a than wild-type BMDCs (Fig. 4 C). Be-
cause an increase in Il23a expression was observed in Batf 2−/− 
innate immune cells, we next analyzed the LPS-induced 
production of proinflammatory cytokines in wild-type and 
Batf 2−/− innate immune cells pretreated with IFN-γ. Con-
sistent with the mRNA expression patterns, the production 
of IL-23 by IFN-γ–pretreated Batf 2−/− PECs, BMMφs, and 
BMDCs was markedly higher than that by wild-type cells, 
whereas IL-6, TNF, and IL-12p40 were normally produced 
by the Batf2−/− cells (Fig. 4, D–F). We also analyzed LPS-in-
duced cytokine production by IFN-γ–untreated innate im-
mune cells. IFN-γ–untreated Batf 2−/− and wild-type PECs, 
BMMφs, and BMDCs produced similar amounts of IL-23 as 
well as IL-6, TNF, and IL-12p40 in response to LPS (Fig. S4, 
A–C). LPS-induced Il23a expression is negatively regulated 
by an IFN-γ–dependent mechanism in Mφs (Sheikh et al., 
2010). Therefore, we evaluated the LPS-induced production 
of IL-23 at the mRNA and protein levels in wild-type and 
Batf2−/− BMMφs pretreated with or without IFN-γ (Fig. 4 G 
and Fig. S4 D). LPS stimulation robustly induced IL-23 expres-
sion in the wild-type BMMφs, whereas IFN-γ pretreatment 
dramatically reduced this LPS-induced IL-23 expression. In 
the Batf 2−/− BMMφs not pretreated with IFN-γ, the expres-
sion of IL-23 in response to LPS was similar to that in wild-
type BMMφs, but the IFN-γ–induced reduction in IL-23 
expression was lower in Batf 2−/− cells stimulated with LPS 
than in stimulated wild-type cells. To investigate whether the 
newly synthesized proteins induced by IFN-γ are involved 
in the inhibition of LPS-induced Il23a expression in innate 
immune cells, BMMφs were pretreated with IFN-γ in the 
presence or absence of cycloheximide (CHX), an inhibitor of 
protein synthesis, and then stimulated with LPS (Fig. S4 E). 
Compared with control cells, LPS-induced Il23a expression 
was greatly increased in CHX-treated cells. Collectively, these 
findings suggest that IFN-γ–induced BATF2 contributes to 
the suppression of the LPS-dependent expression of Il23a, but 
not Il6, Tnf, or Il12b, in innate immune cells.
BAtF2-mediated suppression of IL-23 production by innate 
immune cells during t. cruzi infection
In the next experiment, we analyzed the effect of BATF2 
on T. cruzi–induced IL-23 production. Batf2 expression was 
highest 6 h after T. cruzi infection, and this was maintained 
in both BMMφs and BMDCs even after 12 h of infection 
(Fig.  5 A). BMMφs and BMDCs prepared from wild-type 
and Batf2−/− mice were pretreated with or without IFN-γ 
for 4 h, exhaustively washed, and then infected with T. cruzi. 
At 24 h after infection, the culture supernatants were ana-
lyzed for IL-23, IL-6, IL-12p40, and IL-12p70 with ELI SA 
(Fig.  5, B and C). Even in the absence of IFN-γ pretreat-
ment, Batf2−/− cells showed higher levels of T. cruzi–medi-
ated IL-23 production than wild-type cells. The enhanced 
T. cruzi–dependent response was specific to IL-23, because 
IL-6, IL-12p40, and IL-12p70 production and expression of 
I-Ab, CD80, and CD86 were normally increased in T. cruzi–
infected Batf2−/− BMDCs (Fig.  5, C and D). IFN-γ pre-
treatment caused reduced production of IL-23, but not IL-6, 
IL-12p40, and IL-12p70, in T. cruzi–infected wild-type cells 
(Fig. 5, B and C). However, only a partial reduction in IL-23 
production was observed in Batf2−/− cells. To investigate the 
involvement of BATF2 in the replication of T. cruzi within 
innate immune cells, BMMφs prepared from wild-type and 
Batf2−/− mice were pretreated with or without IFN-γ and 
infected with T. cruzi. At 6 h after infection, cells were thor-
oughly washed and changed to fresh media. At 72 h of culture, 
intracellular T. cruzi numbers in the wild-type BMMφs were 
decreased in an IFN-γ dose–dependent manner (Fig.  5 E). 
The numbers of intracellular parasites in Batf 2−/− BMMφs 
were similarly reduced as IFN-γ concentration increased. 
Moreover, the numbers of trypomastigotes desorbed into the 
culture supernatant of the Batf2−/− BMMφs were similar to 
those of wild-type cells at 3, 4, 5, and 7 d after T. cruzi infec-
tion (Fig. 5 F). These findings indicate that BATF2 is required 
for the down-regulation of T. cruzi–induced IL-23 produc-
tion in innate immune cells, but not for the killing of T. cruzi.
We then analyzed whether IFN-γ is responsible for the 
suppression of IL-23 production by T. cruzi–infected innate 
immune cells. BMMφs and BMDCs prepared from wild-type 
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Figure 4. Increased IL-23 production by Batf2−/− innate immune cells stimulated with LPs after IFn-γ treatment. (A–C) Expression of Il23a, Il6, Tnf, and 
Il12b in wild-type and Batf2−/− PECs (A), BMMφs (B), and BMDCs (C). All data are representative of at least two independent experiments. (D–F) Production of IL-23, 
IL-6, IL-12p40, and TNF by wild-type and Batf2−/− PECs (D), BMMφs (E), and BMDCs (F). Results are mean ± SEM from four independent experiments. *, not detected; 
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Figure 5. Increased IL-23 production by t. cruzi–infected Batf2−/− innate immune cells. (A) Expression of Batf2 in BMMφs and BMDCs after T. cruzi 
infection. All data are representative of two independent experiments (mean values ± SD). (B and C) Production of IL-23, IL-12p40, IL-12p70, and IL-6 by 
T. cruzi–infected wild-type and Batf2−/− BMMφs (B) and BMDCs (C). Data are mean ± SEM from four independent experiments. *, P < 0.05; **, P < 0.03; 
***, P < 0.01. (D) Surface expression of I-Ab, CD86, and CD80 on BMDCs after T. cruzi infection for 36 h. All data are representative of three independent 
experiments. (E) Parasite number per 200 BMMφs prepared from wild-type and Batf2−/− mice. (F) Numbers of trypomastigotes in the culture supernatants. 
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24 h. The culture supernatants were then analyzed for IL-23 
and IL-6 (Fig. 6, A and B). Ifng−/− BMMφs showed markedly 
greater production of IL-23, but not IL-6, than wild-type 
cells. Ifng−/− BMDCs also released higher levels of IL-23 after 
T. cruzi infection than wild-type cells. CD11b+ F4/80+ Mφs 
isolated from the spleens of wild-type and Ifng−/− mice 14 d 
after T. cruzi infection were analyzed for the expression of 
Batf 2 and Il23a (Fig. 6 C). In the CD11b+ F4/80+ Mφs from 
the spleens of Ifng−/− mice, Batf2 expression was severely re-
duced compared with that in the wild-type cells. However, 
the expression of Il23a was higher in the Ifng−/− Mφs than in 
the wild-type Mφs. IL-17 production by CD4+ T cells iso-
lated from the spleens of wild-type and Ifng−/− mice infected 
with or without T. cruzi was evaluated (Fig.  6, D and E). 
IL-17 production by CD4+ T cells stimulated with anti-CD3 
antibody was markedly higher in Ifng−/− mice at 14 d after 
infection than in wild-type mice (Fig. 6 D). Antigen-specific 
IL-17 production was also significantly higher in CD4+ T 
cells from Ifng−/− mice than in those from wild-type mice 
(Fig. 6 E). These findings demonstrate that IFN-γ mediates 
the suppression of Il23a expression in innate immune cells 
and the down-regulation of IL-17 production by CD4+ T 
cells during T. cruzi infection. Because Mφs IL-23 produc-
tion and T cell IL-17 production were similarly increased in 
Ifng−/− and Batf2−/− mice, IFN-γ–induced BATF2 expres-
sion is supposed to be responsible for the suppression of the 
Th17 responses during T. cruzi infection.
To further determine whether the higher levels of IL-23 
production in innate immune cells are involved in the en-
hanced Th17 responses in T. cruzi–infected Batf2−/− mice, 
we generated Il23a−/− mice by the Cas9/CRI SPR-mediated 
genome editing (Fig. S5 A). BMMφs prepared from Il23a−/− 
mice did not produce IL-23 in response to LPS (Fig. S5 B), 
indicating the successful generation of Il23a−/− mice by the 
genome editing method. Il23a−/− mice were used for gener-
ation of Batf2−/−Il23a−/− mice. Wild-type, Batf 2−/−, Il23a−/−, 
and Batf2−/−Il23a−/− mice were infected i.p. with T. cruzi. 
CD4+ T cells isolated from their spleens 20 d after infection 
were analyzed for production of IFN-γ and IL-17 (Fig.  7, 
A–D). There was no difference in IFN-γ production by 
CD4+ T cells stimulated with anti-CD3 antibody (Fig. 7 A) 
or with freeze-thawed T. cruzi in the presence of antigen-pre-
senting cells (Fig. 7 B) between wild-type, Batf2−/−, Il23a−/−, 
and Batf2−/−Il23a−/− mice. In contrast, introduction of Il23a 
deficiency into Batf2−/− mice drastically reduced IL-17 pro-
duction by CD4+ T cells stimulated with anti-CD3 antibody 
(Fig.  7  C). IL-17 production by Batf2−/−Il23a−/− CD4+ T 
cells stimulated with freeze-thawed T. cruzi was also dramat-
ically reduced compared with that by Batf2−/− CD4+ T cells 
(Fig. 7 D). In addition, expression of Il17 and Il22 was mark-Figure 6. Increased expression of Il23a in Mφs and th17 responses 
in t. cruzi–infected Ifng−/− mice. (A and B) Production of IL-23 and 
IL-6 by BMMφs (A) and BMDCs (B). Graphs show mean values ± SEM of 
four independent experiments. *, P < 0.003; **, P < 0.05. (C) Expression of 
Batf2 and Il23a in CD11b+ F4/80+ Mφs from the spleens of wild-type and 
Ifng−/− mice 14 d after infection (n = 3 per group). Mean values ± SD. *, 
P < 0.01. (D and E) IL-17 production by CD4+ T cells from the spleens of 
T. cruzi–infected mice (n = 4) or uninfected mice (n = 3) stimulated with 
anti-CD3 antibody (D) or freeze-thawed T. cruzi (E). Mean values ± SEM. *, 
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edly reduced in liver CD4+ T cells from T. cruzi–infected 
Batf2−/−Il23a−/− mice compared with those in Batf2−/− mice 
(Fig. 7 E). Furthermore, Batf 2−/−Il23a−/− mice exhibited in-
creased parasite load in the livers, hearts, and blood compared 
with Batf2−/− mice (Fig. 8 A), but they showed reduced tis-
sue damage after T. cruzi infection, as determined by lower 
pathological score and reduced serum or plasma concentra-
tion of AST, CK, and CRE (Fig. 8, B and C). These findings 
indicate that increased IL-23 production is responsible for the 
enhanced Th17 responses and immunopathology in T. cruzi–
infected Batf 2−/− mice.
Inhibition of Il23a expression by BAtF2 through 
its interaction with c-Jun
We next investigated how BATF2 selectively down-regu-
lates the expression of Il23a in innate immune cells. Because 
BATF2 does not contain a transcriptional activation domain, 
we suspected that it interacts with other transcription factors 
to regulate downstream genes. Upstream Regulator Analysis 
within Ingenuity Pathway Analysis (IPA) showed the indicated 
transcription factors as significantly enriched upstream regu-
lators of the genes up-regulated in Batf2−/− BMMφs shown 
in Table S1 (Fig. 9 A). IPA was also used to determine the 
protein–protein interaction networks associated with BATF2. 
Among the molecules predicted to be upstream regulators of 
BATF2-dependent genes (Fig. 9 A), IPA showed that BATF2 
binds to c-JUN, JUNB, and RELA/NF-κBp65 (Fig. S5 C). 
Therefore, we analyzed the interactions between BATF2 and 
these molecules with coimmunoprecipitation assays. HEK293 
cells were cotransfected with Flag-BATF2 expression vector 
and c-JUN or JUNB expression vectors. TLR4-expressing 
HEK293 cells were transfected with Flag-BATF2 expression 
vector and stimulated with LPS to analyze the interaction 
between BATF2 and NF-κBp65. The cell lysates were immu-
Figure 7. reduced cd4+ t cell IL-17 production in t. cruzi–infected Batf2−/−Il23a−/− mice. (A–D) Wild-type (n = 18), Batf2−/− (n = 12), Il23a−/− 
(n = 9), and Batf2−/−Il23a−/− (n = 9) mice were infected with T. cruzi for 20 d. CD4+ T cells were isolated from the spleen of T. cruzi–infected mice and stim-
ulated with anti-CD3 antibody (A and C) or freeze-thawed T. cruzi in the presence of antigen-presenting cells (B and D) for 24 h. The culture supernatants 
were analyzed for IFN-γ (A and B) and IL-17 (C and D) by ELI SA. #, P < 0.045; ##, P < 0.006. (E) Expression of Il17a and Il22 in CD4+ T cells from the livers of 
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noprecipitated with anti-Flag antibody, and immunoblotting 
was performed with the indicated antibodies (Fig. S5, D–F). 
Among the three transcription factors, c-JUN and JUNB, but 
not NF-κBp65, interacted with BATF2. It has been shown 
that the heterodimer ATF-2/c-JUN, but not ATF-2/JUNB, 
drives the activity of the Il23a promoter (Liu et al., 2009). 
Figure 8. IL-23–mediated immunopathology in Batf2−/− mice during t. cruzi infection. (A) Parasite equivalents in the livers, hearts, and blood of 
T. cruzi–infected wild-type (n = 18), Batf2−/− (n = 12), Il23a−/− (n = 9), and Batf2−/−Il23a−/− (n = 9) mice (mean values ± SEM). #, P < 0.05. (B) Representative 
sections (top) and pathological score (bottom) in T. cruzi–infected mice. Data are mean values ± SEM. Bars, 100 µm. *, P < 0.009; **, P < 0.006. (C) Concen-
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Therefore, we analyzed whether BATF2 negatively regulates 
c-JUN–ATF-2 heterodimer-mediated activation of the Il23a 
promoter (Fig. 9 B). HEK293 cells were transfected with a 
pLuc vector containing the Il23a promoter region with or 
without BATF2, c-JUN, and ATF-2 expression vectors, and 
luciferase activity in the cell lysates was measured. The in-
troduction of c-JUN and ATF-2 induced activation of the 
Il23a promoter. However, the expression of BATF2 inhibited 
the c-JUN–ATF-2 heterodimer–induced activity of Il23a 
promoter. To further clarify how BATF2 down-regulates 
c-JUN–ATF-2 heterodimer–dependent expression of Il23a, 
HEK293 cells were transfected with the Flag-BATF2 expres-
sion vector, with or without the c-JUN and ATF-2 expression 
vectors, and the cell lysates were immunoprecipitated with 
anti–c-JUN antibody. Immunoblotting was then performed 
with the indicated antibodies (Fig. 9 C). c-JUN interacted in-
dividually with BATF2 and ATF-2. However, in the presence 
of BATF2, c-JUN was associated with BATF2, but not with 
ATF-2. BATF2 lacking the leucine zipper motif (ΔBATF2), 
which contains the protein–protein interaction domain, was 
unable to suppress the LPS-induced Il23a promoter activ-
ity (Fig.  9  D). ΔBATF2 also did not interact with c-JUN 
(Fig. 9 E). When Batf2−/− BMMφs were transfected with a 
vector expressing full-length BATF2 or ΔBATF2, the full-
length protein, but not ΔBATF2, suppressed LPS-induced 
Il23a expression (Fig. 9 F). We also investigated the effect of 
BATF2-mediated disruption of c-JUN/ATF2 heterodimer 
formation on the transcription of Il23a. In addition to in-
nate immune cells, BATF2 was robustly induced by IFN-γ 
in MEFs (Fig. S5 G). Furthermore, expression of Il23a was 
higher in Batf2−/− MEFs stimulated with LPS after IFN-γ 
treatment than in wild-type MEFs (Fig. S5 H). In this con-
text, chromatin immunoprecipitation (ChIP) analysis showed 
that only a little ATF-2 was instantaneously recruited at the 
AP-1–binding site in the Il23a promoter in IFN-γ–pretreated 
wild-type MEFs in response to LPS, whereas NF-κBp65 re-
cruitment to the Il23a promoter was markedly increased, as 
previously described (Mise-Omata et al., 2007; Mühlbauer et 
al., 2008; Fig. 9 G and Fig. S5 I). In contrast, Batf 2−/− MEFs 
showed increased levels of ATF2 and prolonged ATF-2 bind-
ing to the Il23a promoter after LPS stimulation (Fig. 9 G). 
These findings indicate that IFN-γ–inducible BATF2 inhib-
its the recruitment of the c-JUN–ATF-2 heterodimer to the 
Il23a promoter by preventing the formation of the c-JUN–
ATF-2 complex when it directly interacts with c-JUN, lead-
ing to the suppression of Il23a expression.
dIscussIon
In this study, we have demonstrated the mechanism under-
lying regulation of the IL-23–Th17 pathway by BATF2 
during T. cruzi infection. IFN-γ–inducible BATF2 in innate 
immune cells suppressed IL-23 production by preventing 
the formation of the c-JUN–ATF-2 heterodimer, result-
ing in the inhibition of excessive Th17 responses during 
T. cruzi infection.
Compared with wild-type mice, T. cruzi–infected 
Batf2−/− mice showed lower mortality despite the devel-
opment of severe immunopathology. Previous studies have 
shown that parasite-infected Il27ra−/− mice produced high 
amounts of IFN-γ and IL-17, with high mortality rates (Ha-
mano et al., 2003; Villarino et al., 2003; Stumhofer et al., 2006; 
Findlay et al., 2010). However, treatment with anti–IFN-γ 
antibody alone dramatically reduced mortality (Hamano et 
al., 2003), indicating that excessive IL-17 is not implicated in 
the enhanced host lethality during T. cruzi infection. There-
fore, increased IL-17 production in Batf2−/− mice might 
be associated with reduced parasite burden leading to low 
mortality, while inducing the severe immunopathology. In 
Batf2−/−Il23a−/− mice, parasite number was partially reduced 
compared with that in wild-type mice, suggesting the pos-
sibility that BATF2-dependent genes other than Il23a also 
contribute to regulation of the parasite burden.
IL-17 promotes recruitment and activation of neutro-
phils (Kolaczkowska and Kubes, 2013). In accordance with 
the enhanced Th17 responses, a neutrophil-produced tissue 
damage factor, myeloperoxidase (Kolaczkowska and Kubes, 
2013), was highly expressed in tissues of T. cruzi–infected 
Batf2−/− mice, suggesting that increased IL-23 production in 
Batf2−/− mice leads to neutrophil-related local tissue dam-
age through enhanced IL-17 production. In the liver, Il23a 
is expressed in Kupffer cells and CD11c+ DCs (unpublished 
data), indicating that BATF2 might negatively regulate Il23a 
expression in these cells and thereby suppress immuno-
pathological Th17 responses.
Multiple studies have identified several IL-17–produc-
ing cells besides Th17 cells, including invariant natural killer 
T cells, type 3 innate lymphoid cells, activated B cells, and in-
nate γδ T cells (Cua and Tato, 2010; Bermejo et al., 2013). To 
determine whether CD4+ T cell–derived IL-17 is responsible 
for the multiorgan pathology in Batf2−/− mice, we attempted 
to deplete CD4+ T cells in Batf2−/− mice by intraperitoneally 
injecting with monoclonal anti-CD4 antibody after T. cruzi 
infection. However, effective depletion of CD4+ T cells in 
the livers and spleens could not be achieved, although CD4+ 
T cells in the peripheral blood severely decreased (unpub-
lished data). Therefore, it would be an important future issue 
to characterize the IL-17–producing cells in detail during 
T. cruzi infection and to determine whether BATF2 controls 
IL-17 production in these cells by down-regulating Il23a ex-
pression in innate myeloid cells.
In the present study, Ifng−/− BMMφs and BMDCs 
showed higher T. cruzi–mediated IL-23 production than 
wild-type cells, indicating that BATF2, which is induced by 
IFN-γ autocrine signaling in innate immune cells, is respon-
sible for the suppression of IL-23 production after T. cruzi 
infection. We also found that IFN-γ pretreatment leads to se-
verely reduced IL-23 production in wild-type innate immune 
cells infected with T. cruzi, suggesting that BATF2 expression 
in innate myeloid cells is enhanced by potent IFN-γ produc-
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Figure 9. BAtF2 down-regulates Il23a expression through its interaction with c-Jun. (A) Enrichment analysis of the upstream regulators of genes 
up-regulated in Batf2−/− BMMφs. (B) Luciferase activity of Il23a promoter. Data are representative of three independent experiments. Graph show mean 
values ± SD of triplicate wells. *, P < 0.001. RLU, relative light unit. (C) Coimmunoprecipitation (IP) assay with anti–c-JUN antibody for immunoprecipitation 
and the indicated antibodies for immunoblotting. WCL, whole cell lysate. (D) Luciferase activity of Il23a promoter in response to LPS. Data are representative 
of three independent experiments. Mean values ± SD for triplicate wells are shown. *, P < 0.01; n.s., not significant. (E) Coimmunoprecipitation assay with 
anti–c-JUN antibody for immunoprecipitation and the indicated antibodies for immunoblotting. (F) Batf2−/− BMMφs were transfected with the indicated 
vectors by nucleofection and, after 18 h, stimulated with LPS for 1 h, and their expression of Il23a was analyzed. Data are representative of three indepen-
dent experiments. Graphs show mean values ± SD of triplicate measurements. *, P < 0.01. (G) ChIP assay for the Il23a promoter of AP-1–binding site was 
performed with anti–ATF-2 antibody using wild-type and Batf2−/− MEFs. Means ± SD of triplicate PCRs on identical samples. *, P < 0.03; **, P < 0.005; n.s., 
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in Batf2−/− innate immune cells, IFN-γ-mediated reduction 
of IL-23 production was partially observed during T. cruzi 
infection and LPS stimulation. In this regard, it has been 
shown that IFN-γ depresses the recruitment of NF-κBp65 
to the Il23a promoter by inducing histone modification in 
the early phase of the LPS responses (Sheikh et al., 2010). 
Therefore, it appears that IFN-γ suppresses Il23a expression 
in two ways during T. cruzi infection: IFN-γ induces both 
histone modification–mediated and BATF2-mediated reduc-
tion of Il23a expression. In T. cruzi–infected Ifng−/− mice, 
production of IL-17 by CD4+ T cells was markedly increased, 
as previously described (Cobb et al., 2010). IFN-γ–inducible 
T-bet is implicated in the suppression of Th17 cell differen-
tiation by preventing the activation of RORγt (Lazarevic et 
al., 2011). Furthermore, IFN-γ acts on the histone modifica-
tion of Th17-related transcription factors, including RORγt, 
STAT3, and STAT1 (Liu et al., 2015). In this study, we char-
acterized a novel mechanism by which IFN-γ–inducible 
BATF2 contributes to the attenuation of the Th17 responses 
by down-regulating IL-23 production.
A previous study reported that BATF2 is responsible 
for the induction of Tnf and Il12b expression by interact-
ing with IRF1 in LPS-stimulated BMMφs induced by L929 
cell–conditioned medium (Roy et al., 2015). However, we 
observed no changes in Tnf or Il12b expression in IFN-γ 
plus LPS–stimulated Batf2−/− BMMφs, which were induced 
by GM-CSF. LPS-induced expression of Tnf, Ccl5, and Nos2 
was decreased in the absence of BATF2 when we prepared 
BMMφs using L929 cell–conditioned medium (unpublished 
data); however, these genes were normally induced in GM-
CSF–induced Batf2−/− BMMφs (unpublished data). Thus, the 
discrepancy between the two studies may be explained by 
the polarization of Mφs because L929 cell–conditioned me-
dium, containing high levels of M-CSF–induced BMMφs, 
is skewed to the M2Mφ phenotype, whereas GM-CSF-in-
duced BMMφs is skewed to the M1Mφ phenotype. There-
fore, BATF2 might regulate its downstream genes via Mφ 
type–specific mechanisms.
IL-27 suppresses tissue inflammation by inhibiting ef-
fector T cell responses and inducing IL-10–producing Tr1 
cells during parasite infection (Hamano et al., 2003; Stum-
hofer et al., 2006; Hall et al., 2012). IL-27 production was 
slightly decreased in Batf2−/− BMMφs infected with T. cruzi 
(unpublished data). A modest reduction of IL-27 production 
in Batf2−/− BMMφs is not thought to be a major cause of 
the increased Th17 responses in Batf2−/− mice for the fol-
lowing reasons: (a) T. cruzi–infected Batf2−/− mice showed 
normal Th1 responses and IL-10–producing CD4+ T cell 
development; and (b) T. cruzi–infected Batf2−/−Il23a−/− 
mice showed decreased IL-17 production by CD4+ T cells. 
IL-27 suppresses Th17 responses during the chronic phase of 
T. gondii infection (Stumhofer et al., 2006). Thus, it would be 
an important future issue to analyze the effects of BATF2-de-
pendent regulation of IL-27 production on the chronic 
phase of T. cruzi infection.
In the present study, we have demonstrated that IFN-γ–
inducible BATF2 exerts its immunoregulatory function 
through the suppression of Il23a by interacting directly with 
c-JUN in innate immune cells, thereby preventing immuno-
pathological Th17 responses during T. cruzi infection. BATF2 
is also broadly expressed in nonhematopoietic cells, such as 
vascular cells (Murphy et al., 2013; Chmielewski et al., 2014) 
and fibroblasts, as shown in the current study. Therefore, it 
would be interesting to evaluate the precise role of BATF2 
during T. cruzi infection using innate myeloid cell–specific 
BATF2-deficient mice in a future study. In addition, enhanced 
intestinal IL-23 production and Th17 responses, which were 
associated with disturbed intestinal homeostasis, were observed 
in Batf2−/− mice (unpublished data). Thus, BATF2-mediated 
regulation of Th17 responses is not specific to T. cruzi infection, 
but is applicable to several models. Analyses of the involvement 
of BATF2 in other infectious models and Th17-mediated 
immune disorder models would be an interesting future issue.
MAterIALs And MetHods
Mice
C57BL/6 mice were purchased from Japan SLC. Ifng−/− 
mice were generated as described previously (Tagawa et al., 
1997). All mice were maintained under specific pathogen–
free conditions. All animal experiments were conducted in 
accordance with the guidelines of the Animal Care and Use 
Committee of Osaka University.
Generation of Batf2−/− and Il23a−/− mice
To generate Batf2−/− mice, the targeted vector was constructed 
by replacing exon 3 of Batf2 with a neomycin resistance gene 
cassette, and a gene encoding herpes simplex virus thymidine 
kinase driven by a phosphoglycerate kinase promoter was in-
serted into the genomic fragment for negative selection. After 
embryonic day 14, embryonic stem cells were transfected with 
the targeted vector, and colonies doubly resistance to G418 and 
ganciclovir were selected and screened with PCR and Southern 
blot analysis. Homologous recombinants were microinjected 
into blastocysts of female C57BL/6 mice, and the heterozygous 
F1 progeny were intercrossed to obtain Batf2-deficient mice. 
Batf2-deficient mice and their wild-type littermates from these 
intercrosses were confirmed with Southern blot analysis and 
real-time RT-PCR analysis and were used for subsequent ex-
periments. Batf2-deficient mice were backcrossed to C57BL/6 
mice for at least six generations, and Batf2-deficient mice and 
their wild-type littermates from the intercrosses of heterozy-
gous mice were used for the experiments.
To generate Il23a−/− mice by the Cas9/CRI SPR system, 
Il23a-gAS1-F (5′-CAC CGC AGA GCA GTA ATA ATG CTA-
3′) and Il23a-gAS1-R (5′-AAA CTA GCA TTA TTA CTG 
CTC TGC-3′) oligonucleotides and Il23a-gAS2-F (5′-CAC 
CCT GGA ACG CAC ATG CAC CAG-3′) and Il23a-gAS2-R 
(5′-AAA CCT GGT GCA TGT GCG TTC CAG-3′; Thermo 
Fisher Scientific) were annealed and inserted into the BbsI 
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by Ligation high v. 2 (Toyobo). This plasmid was designated 
as px330-Il23a-gAS1 and px330-Il23a-gAS2, respectively. 
The px330-Il23a-gAS1 together with px330-Il23a-gAS2 
vectors were injected into the pronuclei of one-cell-stage 
embryos from B6D2F1 mice. The eggs were cultivated in 
kSOM overnight and then transferred into the oviducts of 
pseudo-pregnant females. 
reagents
The Ca2+ ionophore A23187, PMA, LPS (O55: B5), and an 
anti-Flag antibody (clone M1) were purchased from Sigma- 
Aldrich. Anti-mouse c-JUN (clone H-79), JUNB (clone 
N-17), and NF-kBp65 (clone C-20) antibodies were purchased 
from Santa Cruz Biotechnology, Inc. Anti-ATF2 antibody 
(clone 20F1) was purchased from Cell Signaling Technology.
Preparation of Mφs and dcs
To prepare BMDCs and BMMφs, BM cells were prepared 
from mouse femurs and tibias, passed through a nylon mesh, 
and cultured in RPMI 1640 medium containing 10% FBS, 
100 µM 2-mercaptoethanol, and 10 ng/ml GM-CSF (Pepro-
Tech). After 6 d, nonadherent cells were used as BMDCs, and 
adherent cells were used as BMMφs in the experiments. To 
isolate PECs, mice were injected i.p. with 2 ml of 4% thiogly-
colate medium (Sigma-Aldrich), and cells in the peritoneal 
exudate were isolated from the peritoneal cavity 3 d after 
injection. The cells were incubated for 2 h and then washed 
three times with HBSS. The remaining adherent cells were 
used as PECs in the experiments.
Parasite and experimental infection
The T. cruzi Tulahuen strain was maintained in vitro in 
LLC-MK2 cells, with passage every 3 d. For the in vitro ex-
periments, 5 × 105 Mφs or DCs were infected with 2.5 × 106 
T. cruzi. For the in vivo experiments, the mice were injected 
i.p. with 5 × 102 T. cruzi.
Flow cytometry
The following antibodies were purchased from BD: anti–
mouse-CD16/32 (2.4.G2), APC-conjugated anti-CD11c 
(clone HL3), PE-conjugated anti-CD103 (clone M290), 
PE-Cy7–conjugated anti–Ly-6C (clone AL-21), FITC-con-
jugated anti–Ly-6G (clone 1A8), biotin-conjugated anti-IAb 
(AF6-120.1), PE-conjugated anti-CD80 (B7-1), and strepta-
vidin-APC antibodies. Pacific blue–conjugated anti-CD11b 
(clone M1/70), Percp-Cy5.5–conjugated anti-CD4 (clone 
CK1.5), APC-conjugated anti-CD8 (clone 53–6.7), PE-con-
jugated anti-CD19 (clone 6D5), APC-conjugated anti–IL-
17A (TC11-18H10.1), APC-conjugated anti-F4/80 (BM8), 
FITC-conjugated anti–IFN-γ (clone XMG1.2), and PE-con-
jugated anti–IL-10 (JES5-16E3) antibodies were purchased 
from BioLegend. FITC-conjugated anti-CD86 antibody 
(clone GL1) was purchased from eBioscience. Flow cytomet-
ric analysis was performed with a FAC SCanto II flow cytom-
eter (BD) with FlowJo software (Tree Star). CD11b+ F4/80+ 
Mφs from the spleens of T. cruzi–infected mice were isolated 
with a FAC SAria flow cytometer (BD). The instrumental 
compensation was set in each experiment using single-color, 
two-color, or four-color stained samples.
real-time rt-Pcr
CD4+ T cells isolated from the spleens and livers after T. cruzi 
infection for 20 d were stimulated with 50 ng/ml PMA and 
5 µM calcium ionophore A23187 for 2 h, and total RNA 
was isolated. PECs, BMMφs, and BMDCs were pretreated 
with IFN-γ for 4 h and stimulated with LPS for the indi-
cated periods, and total RNA was isolated. Total RNA was 
isolated using the RNeasy Mini kit (QIA GEN), and 1–2 µg 
of RNA was reverse transcribed with Moloney Murine 
Leukemia Virus Reverse transcription (Promega) and ran-
dom primers (Toyobo) after treatment with RQ1 DNase I 
(Promega). Real-time RT-PCR was performed on a Step 
One Plus Real-Time PCR System (Applied Biosystems) 
using GoTaq qPCR Master Mix (Promega). All values were 
normalized to the expression of Gapdh, encoding glycerald-
hyde-3-phosphate dehydrogenase, and the fold difference in 
expression relative to that of Gapdh is shown. The amplifica-
tion conditions were as follows: 50°C (2 min), 95°C (10 min), 
and 40 cycles of 95°C (15 s) and 60°C (60 s). The following 
primer sets were used: Gapdh, 5′-CCT CGT CCC GTA GAC 
AAA ATG-3′ and 5′-TCT CCA CTT TGC CAC TGC AA-3′; 
Batf, 5′-AGA CAC AGA AAG CCG ACA CC-3′ and 5′-TCA 
GCA CTG ATG TGA AGT AC-3′; Batf2, 5′-GCC CAG CGC 
AGC CGG CAG AA-3′ and 5′-CCA GCT CAG TCT GCA 
AGG CCT-3′; Batf3, 5′-AAG GAC GAT GAC AGG AAAG-
3′ and 5′-CTC TCG TGC TCC TCG TGG AG-3′; Cd86, 
5′-TAC GGA AGC ACC CAC GAT GG-3′ and 5′-AAT AAG 
CTT GCG TCT CCA CG-3′; Fgl2, 5′-AGT GTC CCA GCC 
AAG AAC AC-3′ and 5′-GAT CAG GGG TAA CTC TGT AG-
3′; Gbp7, 5′-TGA GAG AGC AAG AGG TGA AGC TG-3′ and 
5′-ACT TAC CAG AAC CAG GCA CTAC-3′; Gbp8, 5′-CCA 
CAA TGA AAC ATC TGT CCG TGA ACC-3′ and 5′-CCA 
GAG GGA AAC CGT GAT TCT GTC-3′; Ifng, 5′-TCA AGT 
GGC ATA GAT GTG GAA GAA-3′ and 5′-TGG CTC TGC 
AGG ATT TTC ATG-3′; Irf1, 5′-CCG AAG ACC TTA TGA 
AGC TCT TTG-3′ and 5′-GCA AGT ATC CCT TGC CAT 
CG-3′; Il10, 5′-CTG GGT GAG AAG CTG AAG ACC-3′ and 
5′-CAT GGC CTT GTA GAC ACC TTG-3′; Il12b, 5′-GGT 
TTG CCA TCG TTT GCT GG-3′ and 5′-CAT CTT CTT 
CAG GCG TGT CAC-3′; Il12rb1, 5′-CCT GCT TTG CCA 
GCT AGG CG-3′ and 5′-CCT GGG TCC TAA GGG TGA 
GC-3′; Il17a, 5′-GGA CTC TCC ACC GCA ATGA-3′ and 
5′-GGC ACT GAG CTT CCC AGA TC-3′; Il6, 5′-CTG CAA 
GAG ACT TCC ATC CAG TT-3′ and 5′-AAG TAG GGA 
AGG CCG TGG TT-3′; Il22, 5′-TGA TGG CTG TCC TGC 
AGA AA-3′ and 5′-CAG CTG GCG GCA AAG-3′; Il23a, 5′-
CCA GCA GCT CTC TCG GAA TCT-3′ and 5′-ACT GCT 
GAC TAG AAC TCA GGC-3′; Irgm, 5′-AAT AAA ACC AGA 
GAG CCT CA-3′ and 5′-TAA TGG GTC TCT GCC ATG TT-
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5′-ACC GCC CAT CCA GAT GTC AAT-3′; Stat1, 5′-GCG 
TGC AGT GAG TGA GTG AG-3′ and 5′-CAA CAC AAG 
CAA TCA CCA CA-3′; Tnfa 5′-TCC AGG CGG TGC CTA 
TGT-3′ and 5′-CAC CCC GAA GTT CAG TAG ACA GA-3′; 
and Csf2, 5′-TCG AGC AGG GTC TAC GGG GC-3′ and 5′-
TCC GTT TCC GGA GTT GGG GG-3′.
cytokine analysis
CD4+ T cells were isolated from the spleens and livers of 
mice on the indicated days after T. cruzi infection with 
MACS technology (Miltenyi Biotec) and stimulated with 
anti-CD3 antibody or freeze-thawed T. cruzi in the presence 
of antigen-presenting cells in a 1:1:1 ratio for 24 h. PECs, 
BMMφs, and BMDCs were pretreated with 10 ng/ml IFN-γ 
and stimulated with 100 ng/ml LPS for 24 h. BMMφs and 
BMDCs pretreated with or without 10 ng/ml IFN-γ for 
4 h were thoroughly washed and infected with T. cruzi in 
a ratio of 1:5 and cultured for 24 h. The concentrations of 
IL-17, IFN-γ, IL-23, TNF, IL-12p40, IL-12p70, and IL-6 in 
the culture supernatants were measured with the Cytomet-
ric Bead Array kit (BD).
Intracellular cytokine staining
CD4+ T cell intracellular IFN-γ, IL-10, and IL-17A expres-
sion was analyzed with a Cytofix/Cytoperm Plus kit with 
GolgiStop (BD), according to the manufacturer’s instructions. 
In brief, CD4+ T cells were incubated with 50 ng/ml PMA, 
5 µM calcium ionophore A23187, and GolgiStop in complete 
RPMI 1640 at 37°C for 4 h. Surface staining was performed 
with anti-CD4 antibody for 20 min at 4°C, and intracellular 
cytokine staining was performed with anti–IL-17A, anti–IL-
10, and anti–IFN-γ antibodies for 20 min.
t. cruzi killing assay
Wild-type and Batf2−/− BMMφs were pretreated with or with-
out the indicated concentration of IFN-γ for 18 h, rigorously 
washed, and then infected with T. cruzi for 6 h. After washing, 
the cells were cultured for 72 h and fixed. After staining with 
Diff-Quik (Sysmex), the intracellular parasites were counted.
Luciferase assay
HEK293 cells were transfected with the indicated expression 
plasmids together with the reporter plasmid Il23a–Luc and 
the internal control plasmid phRG-TK. After 12 h, lucifer-
ase activities of the whole cell lysates were measured with 
the Dual-Luciferase Reporter Assay System (Promega) and 
a Lumat LB 9507 luminometer (Berthold Technologies). 
TLR4-expressing HEK293 cells were transfected with the 
plasmids. After 12 h, the cells were stimulated with 100 ng/ml 
LPS for 24 h, lysed, and then measured with the Dual-Lucif-
erase Reporter Assay System.
transfection into BMMφs
Batf2−/− BMMφs were transfected with pcDNA3 containing 
the full-length form of BATF2 or the mutant form which 
the leucine zipper motif had been deleted, using nucleofec-
tion (Nucleofector kit for Mouse Macrophages; Lonza). After 
12 h, the cells were stimulated with 100 ng/ml LPS for 3 h, 
and then the expression of Il23a was analyzed.
rnA-seq analysis
Wild-type and Batf2−/− BMMφs pretreated with 10 ng/ml 
IFN-γ for 4  h were stimulated with (designated WT_3 
and KO_3, respectively) or without (designated WT_0 and 
KO_0, respectively) 100 ng/ml LPS for 3 h. Total RNAs were 
extracted from the cells with RNeasy Mini kit (QIA GEN), 
according to the manufacturer’s protocol. The libraries were 
constructed and sequenced at Kazusa DNA Research Insti-
tute (Chiba, Japan) using a SureSelect Strand-Specific RNA 
Library Prep kit (Agilent Technologies), according to the 
manufacturer’s instructions. Sequencing was performed on 
an Illumina HiSeq 2000 sequencer with a TruSeq Rapid 
SBS kit v3 HS (Illumina) in the 50-base single-end mode. 
Illumina Casava 1.8.2 software was used for base calling. The 
low-quality regions of the raw reads were trimmed with 
Btrim. The sequenced reads were mapped to the mouse 
reference genome sequence (mm9) using TopHat v2.0.12. 
The fragments per kilobase of exons per million mapped 
fragments (FPKMs) were calculated using Cufflinks v2.1.1. 
Among the calculated genes with a normalized FPKM value 
>1.0 in WT_3, 98 genes were up-regulated >1.5-fold from 
WT_0 to WT_3 and >2.0-fold from WT_3 to KO_3 (Table 
S1). These results have been deposited in the National Cen-
ter Biotechnology Information Gene Expression Omni-
bus database (GSE81724).
Quantitation of t. cruzi in tissues
The parasite load in the tissue was analyzed as previously 
described (Cencig et al., 2011; Caldas et al., 2012). In brief, 
concentrations of DNA purified from the liver, heart, and 
blood of T. cruzi–infected mice were adjusted to 25 ng/µl. 
Each PCR reaction was performed with 50 ng of genomic 
tissue DNA. The amount of tissue in each PCR was nor-
malized to mouse TNF DNA (Cencig et al., 2011). T. cruzi 
standard curves were generated as previously described (Cal-
das et al., 2012). qPCR was performed on the Step One Plus 
Real-Time PCR System (Applied Biosystems) using GoTaq 
qPCR Master Mix (Promega). The amplification conditions 
were as follows: 95°C for 10 min, 40 cycles of 94°C for 15 s, 
and 64.3°C for 1 min. The following primer sets were used: 
T. cruzi specific primers, 5′-CGA GCT GTT GCC CAC ACG 
GGT GCT-3′ and 5′-CCT CCA AGC AGC GGA TAG TTC 
AGG-3′ (Cencig et al., 2011); and Tnf primers, 5′-TCC CTC 
TCA TCA GTT CTA TGG CCCA-3′ and 5′-CAG CAA GCA 
TCT ATG CAC TTA GAC CCC-3′ (Caldas et al., 2012).
Histopathological analysis
The livers and hearts collected from the mice 49 d after 
T. cruzi infection were fixed in 4% PFA. Paraffin-embedded 
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matoxylin and eosin (H&E) and examined for histopathology 
with inflammatory cell infiltrates using light microcopy. Each 
section of the hearts (Leon et al., 2003) and livers (Barre-
to-de-Albuquerque et al., 2015) was evaluated for inflamma-
tion scores as previously described.
chIP assay
The ChIP assay was performed as previously described, 
with modifications (Kayama et al., 2008). In brief, MEFs 
were stimulated with 100 ng/ml LPS for the indicated 
periods after treatment with 10 ng/ml IFN-γ for 5  h. 
The chromatin was cross-linked with 1% formaldehyde 
at room temperature for 10 min. The MEFs were washed 
with PBS, scraped, and then centrifuged at 800  g. The 
pellet was resuspended in SDS buffer supplemented with 
protease inhibitor. The chromatin was sonicated 15 times 
with 30  s pulses, centrifuged at 1,300  g to remove any 
debris, diluted fivefold with ChIP dilution buffer, and 
precleared with salmon sperm DNA/protein A agarose 
(EMD Millipore). The diluted chromatin was immunopre-
cipitated at 4°C overnight. The immune complexes were 
adsorbed onto salmon sperm DNA/protein A agarose 
beads, and washed once each with low-salt buffer, high-
salt buffer, and LiCl buffer, and then twice with TE buffer. 
The immune complexes were extracted in elution buffer 
and incubated for 4  h at 65°C. The DNA was then ex-
tracted by incubating it in proteinase K buffer for 1 h at 
45°C. The purified DNA was used in qPCR, using 10% 
of each input as the standard. The Il23a promoter-specific 
primer was designed to include the NF-κB–binding site 
or AP-1–binding site. The primer sequences were as fol-
lows: NF-κB–binding site, 5′-TGG CCT CAC TCT GAC 
GTC CA-3′ and 5′-GTA ACA CCC AGG GAA GCA GC-
3′; AP-1–binding site, 5′-AAT CCC ACC TGC TCT GAG 
TC-3′ and 5′-GTA GTC CGA CTT CTA AGC GG-3′.
statistical analysis
Differences between the control and experimental groups 
were evaluated with Student’s t test. Differences of P < 0.05 
were considered to be significant.
online supplemental material
Fig. S1 shows the targeting construct for Batf2−/− mice, 
expression patterns of IFN-γ–dependent genes, and innate 
immune cell population of wild-type and Batf2−/− mice. 
Fig. S2 shows flow cytometric dot plots of cytokine-pro-
ducing CD4+ T cells of T. cruzi–infected mice. Fig. S3 
displays production of IFN-γ and IL-17 in wild-type and 
Batf2−/− naive CD4+ T cells cultured under Th0, Th1, and 
Th17 conditions. Fig. S4 shows cytokine production by 
wild-type and Batf2−/− PECs, BMMφs, and BMDCs. Fig. 
S5 shows the Cas9/gRNA-targeting site for Il23a and the 
analysis of BATF2-binding partners. Table S1, included in a 
separate Excel file, lists genes upregulated in response to LPS 
in Batf2−/− BMMφs pretreated with IFN-γ.
AcknowLedGMents
We thank S. Nishioka, T. Kondo, and Y. Magota for their technical assistance; S. Pareek 
for critical reading of the manuscript; and C. Hidaka for secretarial assistance.
This work was supported by grants from the Ministry of Education, Culture, 
Sports, Science and Technology of Japan and the Japan Agency for Medical Research 
and Development (grant 15gm011002h0006; to K. Takeda) and by the Ichiro Kanehara 
Foundation for the Promotion of Medical Sciences and Medical Care and the Kurata 
Memorial Hitachi Science and Technology Foundation (to H. Kayama).
The authors declare no competing financial interests.
Author contributions: S. Kitada, H. Kayama, R. Koga, and M. Kobayashi designed 
and performed the experiments, analyzed the data, and revised the manuscript. D. 
Okuzaki designed the experiments, analyzed data, and supervised the RNA-seq anal-
ysis. A. Kumanogoh and M. Ikawa supervised the generation of Il23a−/− mice by the 
Cas9/CRI SPR system. Y. Arima and M. Murakami analyzed the Ifng−/− mice. K. Takeda 
supervised the study, designed the experiments, analyzed the data, and wrote 
the manuscript.
Submitted: 11 July 2016
Revised: 8 December 2016
Accepted: 7 February 2017
reFerences
Ahern, P.P., C. Schiering, S. Buonocore, M.J. McGeachy, D.J. Cua, K.J. Maloy, 
and F. Powrie. 2010. Interleukin-23 drives intestinal inflammation 
through direct activity on T cells. Immunity. 33:279–288. http ://dx .doi 
.org /10 .1016 /j .immuni .2010 .08 .010
Barreto-de-Albuquerque, J., D. Silva-dos-Santos, A.R. Pérez, L.R. Berbert, 
E. de Santana-van-Vliet, D.A. Farias-de-Oliveira, O.C. Moreira, E. 
Roggero, C.E. de Carvalho-Pinto, J. Jurberg, et al. 2015. Trypanosoma 
cruzi infection through the oral route promotes a severe infection in 
mice: New disease form from an old infection? PLoS Negl. Trop. Dis. 
9:e0003849. http ://dx .doi .org /10 .1371 /journal .pntd .0003849
Bermejo, D.A., S.W. Jackson, M. Gorosito-Serran, E.V. Acosta-Rodriguez, 
M.C. Amezcua-Vesely, B.D. Sather, A.K. Singh, S. Khim, J. Mucci, D. 
Liggitt, et al. 2013. Trypanosoma cruzi trans-sialidase initiates a program 
independent of the transcription factors RORγt and Ahr that leads to 
IL-17 production by activated B cells. Nat. Immunol. 14:514–522. http ://
dx .doi .org /10 .1038 /ni .2569
Bonney, K.M., J.M. Taylor, E.B. Thorp, C.L. Epting, and D.M. Engman. 
2015. Depletion of regulatory T cells decreases cardiac parasitosis and 
inflammation in experimental Chagas disease. Parasitol. Res. 114:1167–
1178. http ://dx .doi .org /10 .1007 /s00436 -014 -4300 -3
Caldas, S., I.S. Caldas, L.F. Diniz, W.G. Lima, R.P. Oliveira, A.B. Cecílio, I. 
Ribeiro, A. Talvani, and M.T. Bahia. 2012. Real-time PCR strategy 
for parasite quantification in blood and tissue samples of experimental 
Trypanosoma cruzi infection. Acta Trop. 123:170–177. http ://dx .doi .org 
/10 .1016 /j .actatropica .2012 .05 .002
Cencig, S., N. Coltel, C. Truyens, and Y. Carlier. 2011. Parasitic loads in tissues 
of mice infected with Trypanosoma cruzi and treated with AmBisome. 
PLoS Negl. Trop. Dis. 5:e1216. http ://dx .doi .org /10 .1371 /journal .pntd 
.0001216
Chmielewski, S., A. Olejnik, K. Sikorski, J. Pelisek, K. Błaszczyk, C. Aoqui, 
H. Nowicka, A. Zernecke, U. Heemann, J. Wesoly, et al. 2014. STAT1-
dependent signal integration between IFNγ and TLR4 in vascular cells 
reflect pro-atherogenic responses in human atherosclerosis. PLoS One. 
9:e113318. http ://dx .doi .org /10 .1371 /journal .pone .0113318
Cobb, D., and R.B. Smeltz. 2012. Regulation of proinflammatory Th17 
responses during Trypanosoma cruzi infection by IL-12 family 
cytokines. J. Immunol. 188:3766–3773. http ://dx .doi .org /10 .4049 /
jimmunol .1103478
Cobb, D., D. Hambright, and R.B. Smeltz. 2010. T-bet-independent effects of 








niversity user on 03 February 2021
BATF2-dependent host defense against T. cruzi | Kitada et al.1330
T. cruzi infection. J. Leukoc. Biol. 88:965–971. http ://dx .doi .org /10 .1189 
/jlb .0410238
Cua, D.J., and C.M. Tato. 2010. Innate IL-17-producing cells: The sentinels of 
the immune system. Nat. Rev. Immunol. 10:479–489. http ://dx .doi .org 
/10 .1038 /nri2800
da Matta Guedes, P.M., F.R. Gutierrez, F.L. Maia, C.M. Milanezi, G.K. 
Silva, W.R. Pavanelli, and J.S. Silva. 2010. IL-17 produced during 
Trypanosoma cruzi infection plays a central role in regulating parasite-
induced myocarditis. PLoS Negl. Trop. Dis. 4:e604. http ://dx .doi .org /10 
.1371 /journal .pntd .0000604
Erdmann, H., C. Roßnagel, J. Böhme, Y. Iwakura, T. Jacobs, U.E. Schaible, and 
C. Hölscher. 2013. IL-17A promotes macrophage effector mechanisms 
against Trypanosoma cruzi by trapping parasites in the endolysosomal 
compartment. Immunobiology. 218:910–923. http ://dx .doi .org /10 .1016 
/j .imbio .2012 .10 .005
Findlay, E.G., R. Greig, J.S. Stumhofer, J.C. Hafalla, J.B. de Souza, C.J. Saris, 
C.A. Hunter, E.M. Riley, and K.N. Couper. 2010. Essential role for IL-27 
receptor signaling in prevention of Th1-mediated immunopathology 
during malaria infection. J. Immunol. 185:2482–2492. http ://dx .doi .org 
/10 .4049 /jimmunol .0904019
Gaffen, S.L., R. Jain, A.V. Garg, and D.J. Cua. 2014. The IL-23-IL-17 immune 
axis: From mechanisms to therapeutic testing. Nat. Rev. Immunol. 
14:585–600. http ://dx .doi .org /10 .1038 /nri3707
Gazzinelli, R.T., and E.Y. Denkers. 2006. Protozoan encounters with Toll-
like receptor signalling pathways: Implications for host parasitism. Nat. 
Rev. Immunol. 6:895–906. http ://dx .doi .org /10 .1038 /nri1978
Guo, S., D. Cobb, and R.B. Smeltz. 2009. T-bet inhibits the in vivo 
differentiation of parasite-specific CD4+ Th17 cells in a T cell-intrinsic 
manner. J. Immunol. 182:6179–6186. http ://dx .doi .org /10 .4049 /
jimmunol .0803821
Hall, A.O., D.P. Beiting, C. Tato, B. John, G. Oldenhove, C.G. Lombana, G.H. 
Pritchard, J.S. Silver, N. Bouladoux, J.S. Stumhofer, et al. 2012. The 
cytokines interleukin 27 and interferon-γ promote distinct Treg cell 
populations required to limit infection-induced pathology. Immunity. 
37:511–523. http ://dx .doi .org /10 .1016 /j .immuni .2012 .06 .014
Hamano, S., K. Himeno, Y. Miyazaki, K. Ishii, A. Yamanaka, A. Takeda, M. 
Zhang, H. Hisaeda, T.W. Mak, A. Yoshimura, and H. Yoshida. 2003. 
WSX-1 is required for resistance to Trypanosoma cruzi infection by 
regulation of proinflammatory cytokine production. Immunity. 19:657–
667. http ://dx .doi .org /10 .1016 /S1074 -7613(03)00298 -X
Kawai, T., and S. Akira. 2011. Toll-like receptors and their crosstalk with other 
innate receptors in infection and immunity. Immunity. 34:637–650. http 
://dx .doi .org /10 .1016 /j .immuni .2011 .05 .006
Kayama, H., and K. Takeda. 2010. The innate immune response to 
Trypanosoma cruzi infection. Microbes Infect. 12:511–517. http ://dx .doi 
.org /10 .1016 /j .micinf .2010 .03 .005
Kayama, H., V.R. Ramirez-Carrozzi, M. Yamamoto, T. Mizutani, H. Kuwata, 
H. Iba, M. Matsumoto, K. Honda, S.T. Smale, and K. Takeda. 2008. Class-
specific regulation of pro-inflammatory genes by MyD88 pathways 
and IκBζ. J. Biol. Chem. 283:12468–12477 (published errata appear in 
J. Biol. Chem. 2015. 290:4815 and 22446). http ://dx .doi .org /10 .1074 
/jbc .M709965200
Kayama, H., R. Koga, K. Atarashi, M. Okuyama, T. Kimura, T.W. Mak, S. 
Uematsu, S. Akira, H. Takayanagi, K. Honda, et al. 2009. NFATc1 
mediates Toll-like receptor-independent innate immune responses 
during Trypanosoma cruzi infection. PLoS Pathog. 5:e1000514. http ://
dx .doi .org /10 .1371 /journal .ppat .1000514
Kolaczkowska, E., and P. Kubes. 2013. Neutrophil recruitment and function 
in health and inflammation. Nat. Rev. Immunol. 13:159–175. http ://dx 
.doi .org /10 .1038 /nri3399
Lazarevic, V., X. Chen, J.H. Shim, E.S. Hwang, E. Jang, A.N. Bolm, M. 
Oukka, V.K. Kuchroo, and L.H. Glimcher. 2011. T-bet represses TH17 
differentiation by preventing Runx1-mediated activation of the gene 
encoding RORγt. Nat. Immunol. 12:96–104. http ://dx .doi .org /10 .1038 
/ni .1969
Leon, J.S., K. Wang, and D.M. Engman. 2003. Captopril ameliorates 
myocarditis in acute experimental Chagas disease. Circulation. 107:2264–
2269. http ://dx .doi .org /10 .1161 /01 .CIR .0000062690 .79456 .D0
Liu, W., X. Ouyang, J. Yang, J. Liu, Q. Li, Y. Gu, M. Fukata, T. Lin, J.C. He, 
M. Abreu, et al. 2009. AP-1 activated by Toll-like receptors regulates 
expression of IL-23 p19. J. Biol. Chem. 284:24006–24016. http ://dx .doi 
.org /10 .1074 /jbc .M109 .025528
Liu, X., S. Ren, X. Qu, C. Ge, K. Cheng, and R.C. Zhao. 2015. Mesenchymal 
stem cells inhibit Th17 cells differentiation via IFN-γ-mediated SOCS3 
activation. Immunol. Res. 61:219–229. http ://dx .doi .org /10 .1007 /
s12026 -014 -8612 -2
McGeachy, M.J., and S.J. McSorley. 2012. Microbial-induced Th17: Superhero 
or supervillain? J. Immunol. 189:3285–3291. http ://dx .doi .org /10 .4049 
/jimmunol .1201834
McGeachy, M.J., Y. Chen, C.M. Tato, A. Laurence, B. Joyce-Shaikh, W.M. 
Blumenschein, T.K. McClanahan, J.J. O’Shea, and D.J. Cua. 2009. The 
interleukin 23 receptor is essential for the terminal differentiation of 
interleukin 17-producing effector T helper cells in vivo. Nat. Immunol. 
10:314–324. http ://dx .doi .org /10 .1038 /ni .1698
Mise-Omata, S., E. Kuroda, J. Niikura, U. Yamashita, Y. Obata, and T.S. Doi. 
2007. A proximal kappaB site in the IL-23 p19 promoter is responsible 
for RelA- and c-Rel-dependent transcription. J. Immunol. 179:6596–
6603. http ://dx .doi .org /10 .4049 /jimmunol .179 .10 .6596
Miyazaki, Y., S. Hamano, S. Wang, Y. Shimanoe, Y. Iwakura, and H. Yoshida. 
2010. IL-17 is necessary for host protection against acute-phase 
Trypanosoma cruzi infection. J. Immunol. 185:1150–1157. http ://dx .doi 
.org /10 .4049 /jimmunol .0900047
Mühlbauer, M., P.M. Chilton, T.C. Mitchell, and C. Jobin. 2008. Impaired 
Bcl3 up-regulation leads to enhanced lipopolysaccharide-induced 
interleukin (IL)-23P19 gene expression in IL-10(-/-) mice. J. Biol. Chem. 
283:14182–14189. http ://dx .doi .org /10 .1074 /jbc .M709029200
Murphy, T.L., R. Tussiwand, and K.M. Murphy. 2013. Specificity through 
cooperation: BATF-IRF interactions control immune-regulatory 
networks. Nat. Rev. Immunol. 13:499–509. http ://dx .doi .org /10 .1038 /
nri3470
Rangachari, M., N. Mauermann, R.R. Marty, S. Dirnhofer, M.O. Kurrer, V. 
Komnenovic, J.M. Penninger, and U. Eriksson. 2006. T-bet negatively 
regulates autoimmune myocarditis by suppressing local production of 
interleukin 17. J. Exp. Med. 203:2009–2019. http ://dx .doi .org /10 .1084 
/jem .20052222
Rodrigues, M.M., A.C. Oliveira, and M. Bellio. 2012. The immune response 
to Trypanosoma cruzi: Role of Toll-like receptors and perspectives for 
vaccine development. J. Parasitol. Res. 2012:507874. http ://dx .doi .org 
/10 .1155 /2012 /507874
Roy, S., R. Guler, S.P. Parihar, S. Schmeier, B. Kaczkowski, H. Nishimura, 
J.W. Shin, Y. Negishi, M. Ozturk, R. Hurdayal, et al. 2015. Batf2/Irf1 
induces inflammatory responses in classically activated macrophages, 
lipopolysaccharides, and mycobacterial infection. J. Immunol. 194:6035–
6044. http ://dx .doi .org /10 .4049 /jimmunol .1402521
Sheikh, S.Z., K. Matsuoka, T. Kobayashi, F. Li, T. Rubinas, and S.E. Plevy. 
2010. Cutting edge: IFN-γ is a negative regulator of IL-23 in murine 
macrophages and experimental colitis. J. Immunol. 184:4069–4073. http 
://dx .doi .org /10 .4049 /jimmunol .0903600
Stumhofer, J.S., A. Laurence, E.H. Wilson, E. Huang, C.M. Tato, L.M. Johnson, 
A.V. Villarino, Q. Huang, A. Yoshimura, D. Sehy, et al. 2006. Interleukin 
27 negatively regulates the development of interleukin 17-producing T 
helper cells during chronic inflammation of the central nervous system. 








niversity user on 03 February 2021
1331JEM Vol. 214, No. 5
Su, Z.Z., S.G. Lee, L. Emdad, I.V. Lebdeva, P. Gupta, K. Valerie, D. Sarkar, and 
P.B. Fisher. 2008. Cloning and characterization of SARI (suppressor of 
AP-1, regulated by IFN). Proc. Natl. Acad. Sci. USA. 105:20906–20911. 
http ://dx .doi .org /10 .1073 /pnas .0807975106
Tagawa, Y., K. Sekikawa, and Y. Iwakura. 1997. Suppression of concanavalin 
A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) 
mice: Role for IFN-gamma in activating apoptosis of hepatocytes. J. 
Immunol. 159:1418–1428.
Tussiwand, R., W.L. Lee, T.L. Murphy, M. Mashayekhi, W. Kc, J.C. Albring, A.T. 
Satpathy, J.A. Rotondo, B.T. Edelson, N.M. Kretzer, et al. 2012. Compensatory 
dendritic cell development mediated by BATF-IRF interactions. Nature. 
490:502–507. http ://dx .doi .org /10 .1038 /nature11531
Villarino, A., L. Hibbert, L. Lieberman, E. Wilson, T. Mak, H. Yoshida, R.A. 
Kastelein, C. Saris, and C.A. Hunter. 2003. The IL-27R (WSX-1) is 
required to suppress T cell hyperactivity during infection. Immunity. 
19:645–655. http ://dx .doi .org /10 .1016 /S1074 -7613(03)00300 -5
Yoshimura, T., A. Takeda, S. Hamano, Y. Miyazaki, I. Kinjyo, T. Ishibashi, A. 
Yoshimura, and H. Yoshida. 2006. Two-sided roles of IL-27: Induction 
of Th1 differentiation on naive CD4+ T cells versus suppression 
of proinflammatory cytokine production including IL-23-induced 
IL-17 on activated CD4+ T cells partially through STAT3-dependent 
mechanism. J. Immunol. 177:5377–5385. http ://dx .doi .org /10 .4049 /








niversity user on 03 February 2021
